Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Time-dependent effect of statins on platelet function in hypercholesterolaemia.

L Puccetti1, A L Pasqui, M Pastorelli

  • 1Department of Clinical Medicine and Immunological Sciences, Center for Metabolic Diseases and Atherosclerosis, University of Siena, Siena, Italy. puccetti@unisi.it

European Journal of Clinical Investigation
|January 22, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

UNITY: A low-field magnetic resonance neuroimaging initiative to characterize neurodevelopment in low and middle-income settings.

Developmental cognitive neuroscience·2024
Same author

Trichoscopy as a monitoring tool in assessing treatment response in scalp pemphigus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Self-induced nail disorders (SINDs): What do we know so far?

Annales de dermatologie et de venereologie·2023
Same author

Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic alopecia.

Journal of cosmetic dermatology·2023
Same author

Evaluating the effect of COVID-19 incidence on Emergency Departments admissions. Results from a retrospective study in Central Italy during the first year of pandemic.

Annali di igiene : medicina preventiva e di comunita·2023

Statins reduce platelet activity, with effects varying by type and timing. Early statin action on platelet-associated oxidized LDL (Pox-LDL) influences platelet function more than cholesterol reduction.

Area of Science:

  • Cardiovascular Pharmacology
  • Platelet Biology
  • Lipid Metabolism

Background:

  • Statins are known to reduce platelet activity, a beneficial effect for vascular thrombotic events.
  • The precise relationships between cholesterol reduction, the timing of antiplatelet effects, underlying mechanisms, and statin dosage are not fully understood.

Purpose of the Study:

  • To evaluate the impact of simvastatin, atorvastatin, fluvastatin, and pravastatin on platelet function in hypercholesterolemic subjects.
  • To investigate the association with low-density lipoprotein cholesterol (LDL-C), oxidized LDL (ox-LDL), and antiport mechanism modifications.

Main Methods:

  • Sixteen subjects per treatment group received simvastatin (20 mg/day), atorvastatin (10 mg/day), fluvastatin (40 mg/day), or pravastatin (40 mg/day).
  • Evaluations included platelet surface P-selectin (P-sel), lipid profile, ox-LDL, platelet-associated ox-LDL (Pox-LDL), platelet cholesterol, antiport mechanisms, and NO synthase, measured weekly for one month.

Related Experiment Videos

Main Results:

  • A strong correlation was observed between enhanced P-sel and Pox-LDL (r=0.68, P<0.01).
  • Platelet activity decreased after 1, 2, 3, and 4 weeks for simvastatin, atorvastatin, fluvastatin, and pravastatin, respectively.
  • Simvastatin, atorvastatin, and fluvastatin modulated Pox-LDL early, while LDL-C reduction and antiport modifications were later effects, particularly notable with pravastatin.

Conclusions:

  • Different statins exhibit distinct impacts on platelet function.
  • The initial antiplatelet effect appears primarily linked to interference with Pox-LDL, preceding significant LDL-C reduction or antiport mechanism changes.